6 Iconography
4 @@#116640@@
Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text

Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates

Anaesthesia Critical Care & Pain Medicine
Sous presse. Epreuves corrigées par l'auteur. Disponible en ligne depuis le jeudi 8 août 2019
Doi : 10.1016/j.accpm.2019.07.014
T regulatory cells activation and distribution are modified in critically ill patients with acute respiratory distress syndrome: A prospective single-centre observational study

Sebastien Halter a, b, c, 1, Lucrèce Aimade b, c, Michèle Barbié b, Hélène Brisson a, 1, Jean-Jacques Rouby a, 1, Olivier Langeron a, 1, David Klatzmann b, c, Michelle Rosenzwajg b, c, Antoine Monsel a, b, c, , 1
a Multidisciplinary Intensive Care Unit, Department of Anaesthesiology and Critical Care, La Pitié-Salpêtrière Hospital, Public Hospitals of Paris (AP–HP), Sorbonne University, 75013 Paris, France 
b Public Hospitals of Paris (AP–HP), La Pitié-Salpêtrière Hospital, Biotherapy (CIC-BTi) and Inflammation-Immunopathology-Biotherapy Department (i2B), 75651 Paris, France 
c Sorbonne University, INSERM, UMR_S 959, Immunology-Immunopathology-Immunotherapy (i3), 75651 Paris, France 

Corresponding author at: Polyvalent Critical Care Unit, Department of Anaesthesiology and Critical Care Medicine, Pitié-Salpêtrière Hospital Group, 47–83, boulevard de l’Hôpital, 75651 Paris cedex 13, France.Polyvalent Critical Care Unit, Department of Anaesthesiology and Critical Care Medicine, Pitié-Salpêtrière Hospital Group47–83, boulevard de l’HôpitalParis cedex 1375651France

Acute respiratory distress syndrome (ARDS) is a common and fatal inflammatory condition. Whether T regulatory cells (Tregs) are beneficial or detrimental remains controversial, and longitudinal studies are lacking. Phenotyping of Tregs activation markers has been poorly reported. We aimed to evaluate quantitative and functional alterations in blood and bronchoalveolar Treg phenotype of ARDS patients.


We performed a single-centre observational study in a French intensive care unit. The study enrolled 60 ARDS and 45 non-ARDS patients. Patients under 18years old or with immunosuppression (native or acquired) were excluded. Tregs phenotypes were assessed by flow cytometry, while cytokines were measured by multiplex-based assays in blood and bronchoalveolar samples collected over 3weeks after the onset of ARDS.


Blood Tregs/CD4+ percentage (median %, 25–75% interquartile) was higher in ARDS patients than in non-ARDS patients: 12.1% [9.0–16.0] versus 9.9% [8.1–12.6], P =0.01. Alveolar Tregs/CD4+ percentage was lower in ARDS patients than in non-ARDS patients: 10.4% [6.3–16.6] versus 16.2% [12.4–21.1], P =0.03. In ARDS patients, Tregs activation was reduced in the blood and increased in the alveolus, compared to non-ARDS patients. ROC analysis revealed a threshold of 10.4% for the Tregs/CD4+ percentage in the blood collected within the first week of ARDS to discriminate between survivors and non-survivors (sensitivity: 75%; specificity 76%; area under the curve [95% confidence interval]: 0.72 [0.5–0.9]).


Quantitative and functional alterations in Treg phenotype were observed in patients with ARDS. Whether rebalancing Tregs phenotype with therapeutic interventions would be beneficial deserves further investigations.

The full text of this article is available in PDF format.

Keywords : Acute respiratory distress syndrome, T regulatory cells, Immune phenotype, Innate lymphoid cells, T helper polarisation

Abbreviations : ARDS, BAL, CD, CTLA-4, FoxP3, GITR, HLA, ICU, IL, ILCs, IFN, IQR, LAG, LAP, NK, ROC, SAPS 2, SD, SOFA, Teff, TGF-β1, Th, TNF, Tregs, VAP

© 2019  Société française d'anesthésie et de réanimation (Sfar)@@#104156@@
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Article Outline